Growth Metrics

Allurion Technologies (ALUR) Debt Ratio (2022 - 2024)

Allurion Technologies posted quarterly Debt Ratio of 0.65 for Q1 2024, up 20.52% on a QoQ basis from 0.54 in Q4 2023.

Allurion Technologies (ALUR) has 3 years of Debt Ratio data on file, last reported at 0.65 in Q1 2024.

  • For the quarter ending Q1 2024, Debt Ratio changed N/A year-over-year to 0.65; the trailing twelve-month figure through Mar 2024 stood at 0.65 (changed N/A YoY), and the FY2023 full-year result was 0.54, down 48.12% from the prior year.
  • Debt Ratio for Q1 2024 stood at 0.65, up from 0.54 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.04 in Q4 2022 and bottomed at 0.48 in Q3 2023.
  • The 3-year median for Debt Ratio is 0.65 (2024), against an average of 0.75.
  • Peak annual rise in Debt Ratio reached 48.12% in 2023, while the deepest fall reached 48.12% in 2023.
  • A 3-year view of Debt Ratio shows it stood at 1.04 in 2022, then tumbled by 48.12% to 0.54 in 2023, then climbed by 20.52% to 0.65 in 2024.
  • The last three Debt Ratio figures came in at 0.65 (Q1 2024), 0.54 (Q4 2023), and 0.48 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 Allurion Technologies - - 1.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 0.65
Dec 31, 2023 0.54
Sep 30, 2023 0.48
Jun 30, 2023 1.03
Dec 31, 2022 1.04